This announcement is a separate document:
先聲藥業：建議修訂二零二一年受限制股份單位計劃
SIMCERE PHARMA: PROPOSED AMENDMENTS TO THE 2021 RSU SCHEME
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.